Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
Moringa Acquisition Corp Silexion’s first technology product, Loder™, efficiently examined in a multinational Section 2a ...
Read more
